Structural Determinants of Mammalian Prion Aggregation
哺乳动物朊病毒聚集的结构决定因素
基本信息
- 批准号:10239229
- 负责人:
- 金额:$ 1.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2021-09-10
- 项目状态:已结题
- 来源:
- 关键词:AffectAmyloidAmyloidosisAnimal DiseasesBehavioral SymptomsBiochemicalBiologyCaringCharacteristicsChemicalsCodeCommunicable DiseasesContractsCryoelectron MicroscopyCrystallizationCrystallographyDementiaDiagnosisDiseaseDisease OutbreaksDisease susceptibilityElectronsEndopeptidase KEnvironmental HealthEventExhibitsFDA approvedFiberFilamentGeneticGenetic PolymorphismGoalsHumanInfectious AgentLengthLinkMammalsMethodsMicro Electron DiffractionMicrotusMolecularMorphologyNeurodegenerative DisordersOrganismPathologyPatientsPatternPeptide HydrolasesPeptidesPlayPolymorphPopulationPrPPrP sequencePredispositionPrion DiseasesPrionsPropertyProteinsProteolysisReactionRecombinantsResistanceResolutionRoleSamplingSequence AlignmentStretchingStructureTherapeuticVariantbasebeta pleated sheetdisease phenotypedisease transmissiondisorder preventionexperimental studyfrontierinterestnon-geneticparticlepathogenpreventpsychiatric symptomresponsestructural biologytherapeutic developmenttherapy designtherapy developmenttransmission processwild-type PrP
项目摘要
Project Summary:
Prion diseases are neurodegenerative disorders that pose a threat to human and environmental health. These
illnesses have genetic and nongenetic causes, can be environmentally acquired, and have the ability to remain
infectious in the absence of a host organism for extended periods. Aggregation of misfolded prion protein
(PrPSc) correlates with disease, but the mechanism behind aggregation is not fully understood, gravely
hindering the development of therapeutics to prevent fibrillation and sickness. The β2α2 loop of mammalian
prion protein has previously been demonstrated to be a key region implicated in disease transmission. A
crystal structure from a nine-residue segment encoding the β2α2 loop of the bank vole prion has demonstrated
structural characteristics and stability characteristic of full-length prion fibers. Building on this structure,
structures of PrP aggregates that convey information on stability and infectivity will be pursued. To achieve this
goal, ordered aggregates of PrP segments that have been described to play a role in disease transmission in
various species with a range of prion disease susceptibility will be biochemically and structurally characterized.
Constructs incorporating disease modulating regions will be recombinantly expressed, purified, and fibrillized to
assess stability, proteinase K resistance, and fiber morphologies. These properties will be compared against
those observed in fibrils derived from diseased animals. A combination of crystallography and single particle
Cryo-EM will be used to determine the atomic arrangement of each misfolded PrP. These aims will be
achieved through the application of frontier methods in macromolecular crystallography including electron
micro-diffraction (MicroED). The resulting structures will provide a molecular explanation for a nearly three-
hundred-year-old mystery in prion biology and protein pathology and will help distinguish infectious from non-
infectious amyloids, revealing structural code for prion transmission barriers.
!
项目总结:
Pron病是一种神经退行性疾病,对人类和环境健康构成威胁。这些
疾病有遗传和非遗传原因,可以在环境中获得,并有能力保持
在长时间没有寄主生物体的情况下具有传染性。错误折叠的Pron蛋白的聚集
(PrPSc)与疾病相关,但聚集背后的机制尚未完全了解,严重
阻碍预防纤颤和疾病的治疗方法的发展。哺乳动物的β-2-α-2环
Prion蛋白此前已被证明是参与疾病传播的关键区域。一个
编码银行田鼠β2α2环的9个残基片段的晶体结构已经证明
全长Pron纤维的结构特征和稳定性特征。在这个结构的基础上,
将寻求PrP聚集体的结构,以传达关于稳定性和传染性的信息。要做到这一点
目标,PrP片段的有序聚集,已被描述为在疾病传播中发挥作用
将从生化和结构上描述具有一系列Pron疾病易感性的各种物种。
含有疾病调节区的构建物将被重组表达、纯化和纤维连接以
评估稳定性、对蛋白酶K的抵抗力和纤维形态。这些属性将与
在患病动物的纤维中观察到的那些。结晶学和单粒子的结合
冷冻电子显微镜将被用来确定每个错误折叠的PrP的原子排列。这些目标将是
通过在包括电子在内的大分子结晶学中应用前沿方法实现的
微电子衍射(MicroED)。由此产生的结构将为近三个-
在普里子生物学和蛋白质病理学中的百年谜团,将有助于区分感染性和非传染性
传染性淀粉样蛋白,揭示了Pron传递障碍的结构代码。
好了!
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Calina Glynn其他文献
Calina Glynn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Calina Glynn', 18)}}的其他基金
Structural Determinants of Mammalian Prion Aggregation
哺乳动物朊病毒聚集的结构决定因素
- 批准号:
10080024 - 财政年份:2019
- 资助金额:
$ 1.27万 - 项目类别:
相似国自然基金
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
- 批准号:
- 批准年份:2020
- 资助金额:63 万元
- 项目类别:面上项目
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
- 批准号:81870666
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
- 批准号:81601123
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
- 批准号:30971012
- 批准年份:2009
- 资助金额:35.0 万元
- 项目类别:面上项目
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
- 批准号:30570622
- 批准年份:2005
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
The disease of 21 century: Development of a novel therapy for ATTR amyloidosis based on the pathogenesis of amyloid formation mechanism
21世纪的疾病:基于淀粉样蛋白形成机制的ATTR淀粉样变性新疗法的开发
- 批准号:
22K07528 - 财政年份:2022
- 资助金额:
$ 1.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Amyloid Transcription Block Survival - Deriving Functionally Active Peptide Inhibitors of Amyloidosis and Toxicity
淀粉样蛋白转录阻断存活 - 衍生淀粉样变性和毒性的功能活性肽抑制剂
- 批准号:
2605106 - 财政年份:2021
- 资助金额:
$ 1.27万 - 项目类别:
Studentship
Amyloid Transcription Block Survival - Deriving Functionally Active Peptide Inhibitors of Amyloidosis and Toxicity
淀粉样蛋白转录阻断存活 - 衍生淀粉样变性和毒性的功能活性肽抑制剂
- 批准号:
2598875 - 财政年份:2021
- 资助金额:
$ 1.27万 - 项目类别:
Studentship
Analysis of cerebral amyloid angiopathy in hereditary ATTR amyloidosis
遗传性ATTR淀粉样变性脑淀粉样血管病分析
- 批准号:
21K15701 - 财政年份:2021
- 资助金额:
$ 1.27万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of novel therapy for cardiac amyloidosis by identifying transthyretin-derived amyloid fibril deposition promoting factor
通过鉴定转甲状腺素蛋白衍生的淀粉样原纤维沉积促进因子开发心脏淀粉样变性的新疗法
- 批准号:
19K08493 - 财政年份:2019
- 资助金额:
$ 1.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on the transmission of avian AA amyloidosis mediated by amyloid in the environment
淀粉样蛋白介导的禽类AA淀粉样变性在环境中的传播研究
- 批准号:
17K17702 - 财政年份:2017
- 资助金额:
$ 1.27万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis
制定改善轻链淀粉样变性淀粉样蛋白病理学的策略
- 批准号:
10677553 - 财政年份:2016
- 资助金额:
$ 1.27万 - 项目类别:
Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis
制定改善轻链淀粉样变性淀粉样蛋白病理学的策略
- 批准号:
9270017 - 财政年份:2016
- 资助金额:
$ 1.27万 - 项目类别:
Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis
制定改善轻链淀粉样变性淀粉样蛋白病理学的策略
- 批准号:
10057800 - 财政年份:2016
- 资助金额:
$ 1.27万 - 项目类别:
Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis
制定改善轻链淀粉样变性淀粉样蛋白病理学的策略
- 批准号:
9104759 - 财政年份:2016
- 资助金额:
$ 1.27万 - 项目类别:














{{item.name}}会员




